Devon Energy Corp vs DexCom, Inc. — how do they compare? Devon Energy Corp trades at $48.3 (market cap $53.81B), while DexCom, Inc. trades at $84.14 (market cap $31.86B). The key difference: Devon Energy Corp is the larger of the two by market cap, and Devon Energy Corp pays a 2.62% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Devon Energy Corp for 136 Days and DexCom, Inc. for 62 Days on average.
| DVN | DXCM | |
|---|---|---|
Market Cap | $53.81B | $31.86B |
Volume | 11,556,740 | 3,607,070 |
Sector | Energy | Health |
52-Week High | $52.07 | $92.34 |
52-Week Low | $31.74 | $54.84 |
Typical Hold Time | 136 Days | 62 Days |
Enterprise Value | $64.55B | $31.32B |
Dividend Yield | 2.62% | — |
Signals from Pluang's Aura AI — not financial advice
Devon Energy (DVN) trades at $48.26, up 0.79% with a bullish technical outlook. The stock shows strong fundamentals with a P/E of 10.63 and net margin of 16.67%, supported by recent earnings beats. Analyst consensus is strongly bullish with a $62.53 price target, representing 30% upside potential. Recent news highlights activist investor pressure for strategic alternatives including potential sale, while BP shows interest in acquiring Eagle Ford assets.
DVN presents compelling value with attractive valuation metrics and solid profitability. Key opportunities include potential asset sales and Permian Basin strength, while risks involve oil price volatility and execution of strategic initiatives. The stock's current valuation discount to analyst targets suggests significant upside if operational improvements materialize.
DexCom (DXCM) trades at $84.11, down 0.23% on the day, with a bearish technical signal but strong fundamental performance. The company reported Q2 2026 EPS of $0.70, beating expectations, and has shown consistent revenue growth, with 2025 revenue reaching $4.66 billion and net income of $836.3 million. Analyst consensus is strongly bullish with an 80.77% buy rating and a $95.07 price target. Recent news highlights growth opportunities in Type 2 diabetes care and key executive promotions.
The outlook for DXCM is positive due to robust earnings beats, expanding market opportunities, and strong institutional support. However, risks include competitive pressures, reimbursement challenges, and a high valuation with a P/E of 33.38. The stock presents a growth opportunity but requires monitoring of execution against these risks.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →